Literature DB >> 18324381

[A 67-year-old patient with recurrent hypoglycemia].

A K Schober1, E G Hahn, I A Harsch.   

Abstract

A 67 year old female patient was admitted to our clinic with recurrent hypoglycemia in December 2006. Laboratory findings revealed an elevated insulin, and C-peptide. Imaging techniques revealed a tumor of the pancreas involving the spleen with metastases of the liver, expressing somatostatin receptors. Ultrasound-guided biopsy was performed and confirmed the suspected insulinoma. Since the hypoglycemias could not sufficiently be controlled by subcutaneous administration of octreotide and by oral glucose intake, surgical debulking was performed in a palliative intention. After resection the patient was free of hypoglycemia. In case of diagnosed insulinoma, underlying MEN (multiple endocrine neoplasia) should be considered. Excision of the tumor is recommended in patients with benign solitary insulinomas. If complete excision is impossible, there are several therapeutic options that aim at preventing hypoglycemia. Thus, in contrast to other extended tumors, surgery is reasonable in malignant insulinoma even in case of metastatic disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18324381     DOI: 10.1007/s00108-008-2046-7

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  14 in total

1.  Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients.

Authors:  Saila Kauhanen; Marko Seppänen; Heikki Minn; Risto Gullichsen; Anna Salonen; Kalle Alanen; Riitta Parkkola; Olof Solin; Jörgen Bergman; Timo Sane; Jorma Salmi; Matti Välimäki; Pirjo Nuutila
Journal:  J Clin Endocrinol Metab       Date:  2007-01-16       Impact factor: 5.958

2.  The diagnosis of ectopic focal hyperinsulinism of infancy with [18F]-dopa positron emission tomography.

Authors:  Khalid Hussain; Marko Seppänen; Kirsti Näntö-Salonen; N Scott Adzick; Charles A Stanley; Paul Thornton; Heikki Minn
Journal:  J Clin Endocrinol Metab       Date:  2006-05-09       Impact factor: 5.958

3.  The occurrence of biogenic monoamines in the mammalian endocrine pancreas.

Authors:  L Cegrell
Journal:  Acta Physiol Scand Suppl       Date:  1968

4.  Clinical features and morphological characterization of 10 patients with noninsulinoma pancreatogenous hypoglycaemia syndrome (NIPHS).

Authors:  Justin G S Won; Hsiao-Shan Tseng; An-Hang Yang; Kam-Tsun Tang; Tjin-Shing Jap; Chen Hsen Lee; Hong-Da Lin; Niculina Burcus; Gary Pittenger; Aaron Vinik
Journal:  Clin Endocrinol (Oxf)       Date:  2006-11       Impact factor: 3.478

5.  Hypoglycemic disorders.

Authors:  F J Service
Journal:  N Engl J Med       Date:  1995-04-27       Impact factor: 91.245

Review 6.  Developments in PET for the detection of endocrine tumours.

Authors:  B Eriksson; H Orlefors; K Oberg; A Sundin; M Bergström; B Långström
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2005-06       Impact factor: 4.690

7.  Medical treatment of benign insulinoma using octreotide LAR: a case report.

Authors:  Mikiya Usukura; Takashi Yoneda; Nobushige Oda; Yasuhiro Yamamoto; Hiroyuki Takata; Kenkou Hasatani; Yoshiyu Takeda
Journal:  Endocr J       Date:  2006-11-24       Impact factor: 2.349

8.  Imaging of advanced neuroendocrine tumors with (18)F-FDOPA PET.

Authors:  Alexander Becherer; Monica Szabó; Georgios Karanikas; Patrick Wunderbaldinger; Peter Angelberger; Markus Raderer; Amir Kurtaran; Robert Dudczak; Kurt Kletter
Journal:  J Nucl Med       Date:  2004-07       Impact factor: 10.057

9.  Complete clinical remission and disappearance of liver metastases after treatment with somatostatin analogue in a 40-year-old woman with a malignant insulinoma positive for somatostatin receptors type 2.

Authors:  Stefano Romeo; Massimo Milione; Alessandra Gatti; Mara Fallarino; Vito Corleto; Susanna Morano; Marco Giorgio Baroni
Journal:  Horm Res       Date:  2006-02-09

10.  Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma.

Authors:  C G Moertel; M Lefkopoulo; S Lipsitz; R G Hahn; D Klaassen
Journal:  N Engl J Med       Date:  1992-02-20       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.